Banner fertilidade feminina

Fertilidade Feminina em Oncologia - Turma 3

Ff
8 vídeos
4 provas
18 textos
6 horas

Descrição do curso

Oferecer conteúdo básico voltados a orientação adequada sobre o impacto do tratamento contra o câncer na fertilidade Feminina.

Categoria: Tratamento


Informações gerais

Objetivo

Ao final deste curso, o aluno deve estar apto a saber identificar os casos com maior risco de ter sua saúde reprodutiva prejudicada, assim como o direcionamento das possibilidades existentes para preservá-la.

Público alvo

Médico Generalista (pediatra geral, pronto-socorro, ESF) em busca de aprimoramento, médicos recém-formados, estudantes de medicina em fase de conclusão de curso. 

Metodologia

Buscando alcançar a experiência de aprendizagem eficiente e inovadora, baseamos nossa metodologia nas melhores práticas de ensino à distância aliadas à poderosa combinação de conteúdos de qualidade e recursos audiovisuais estimulantes.

Teremos a oportunidade de apresentar aos alunos, vídeo aulas permeadas por entrevistas, vídeo cases, demonstração de procedimentos e animações além de promover diversos tipos de interações.



Bibliografia

  • 1.Meirow D. ; Levron J.; Edar-Geva T.;Hardan I.; Fridman E.; Yemini Z.; Dor j. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril 87(2): 418 e.7-418 e 15, 2007 feb.

  • 2.Hamre H.; Kiserud C.E.; Thorsby P.M.; Fossa S.D. Gonadal function and parenthood 20 years after treatment for chilhood lymphoma: a cross- sectional study. Pediatr Blood Cancer;  59(2): 271-7, 2012 Aug.

  • 3.Schuck A.; Hamelmann V.; Bramswig J.H.; Konemann S.; Rube C.; Hesselmann S.; Riesembeck D.; Horst E.; Bolling T.; Paulussen H.; Willich N. Ovarian function follwing pelvic irradiation in prepubertal and pubertal girls and youn g adult women. Strahlenther Onkol; 181(8): 534-9, 2005 aug.

  • 4. Amr H.; El-Shalakany S. Ali; Abeer A.A.; Shereen A.E.; Enam A.H. Ovarian function in female survivors of childhood malignancies. Peadiatric Hematology and Oncology; 30(4), 2013

  • 5. Blumenfeld Z. Chemoterapy and fertility. Best Pract Res Clin Obstet Gynaecol; 26(3): 379-90, 2012 jun.

  • 6. Partridge A.; Gelber S.; Gelber R.D. Age of menopause among women whonremais premenopausal following treatment for early breast câncer: long term results from international breast câncer study. Eur. J. Cancer; 43: 1646-1653, 2007

  • 7.Johnston R.J.; Wallace W.H. Normal ovarian function and assessment of ovarian reserve in the survivor of childhood câncer. Pediatr Blood Cancer; 53(2): 296-302, 2009 aug

  • 8. Hudson M.M.; Reproductive outcomes for survivors of childhood câncer. Obstet. Gynecol.; 116(5):1171-1183, 2010, nov.

  • 9. Schultheis B.; Nijmeijer B.A.; Yin H.; Gosden R.G.; Melo J.V. Imatinib mesylate at therapeutic doses has no impact on follucilogenesis or spermatogenesis in a leukaemic mouse model. Leuk Res; 36(3): 271-4, 2012 mar

  • 10. Curran M.P.; Croom K.F. Spotlight on imatinib mesylate in chronic myeloid leucemia. BioDrugs; 18(3): 207-10, 2004

  • 11. Sarafoglou K.; Boulad F.; Gillio A.; Sklar C. Gonadal function after boné marroy transplatation for acute leucemia durinf childhood. J. Pediatr.; 130(2):210-6, 1997 feb.

  • 12.Sanders J.E.; Buckner C.D.; Amos D.; Levy W.; Appelbaum F.R.; Doney K. Ovarian function following marrow transpantation for aplastic anemia or leucemia. J. Clin. Oncol.; 6(5):813-8, 1988 may

  • 13.Watanabe T.; Matsubara S.; Saito Y.; Mugishima H.; Suzuki M. Pregnant woman with na extremelly uterus due to pelvic irradiation in chilhood. J. Obstet. Gynaecol Res.;38(3):559-561, 2012 mar

  • 14.El-Hemaid I.; Robinson S.E. Management of haematological malignancy in pregnancy. Best Pract. Res. Clin. Obstet Gynaecol; 26(1):149-160, 2012 feb

  • 15.Brewer M.; Kueck A.; Runowicz C.D. Chemotherapy in pregnancy. Clin. Obstet. Gyneaecol.; 54(4):602-618, 2011 dec

  • 16.Cohen J.B.; Blum K.A. Evaluation and management of lymphoma and leucemia in pregnancy. Clin. Obstet. Gynaecol.; 54(4):556-566, 2011 dec

  • 17. Amourak S.; Alaoui F.F.; Javi S.; Bouguern H.; Chaara H.; Melhouf M.A. Lymphoma and pregnancy. Pan Afr. Med. J.; 19:317, 2014 nov

  • 18. Oksuzyan S.; Crespi C.M.; Cockburn M.; Mezei G.; Kheifets L. Birth weight and other perinatal characteristics and childhood keukemia in California. Cancer epidemiol.; 36(6):e359-e365, 2012 dec

  • 19.Naval D.; Nazha A.; Kantarjian H.M.; Haltom R.; Ravandi F. Treatment of hairy cell leucemia during pregnancy: are purine analogues and rituximab viable therapeutics options. Clin. Lymphoma Myeloma Leuk. 13(1):86-89, 2012 sep.

  • 20.Chelghoum Y.; Vey N.; raffoux E.; Huguet F.; Prneaux A.; Witz B. Acute leukemia during pregnancy; a report on 37 patients and a review of the literature. Cancer; 104(1):110-117, 2005

  • 21. Ali R.; Ozkalemkas F.; Ozçelik T.; Ozan U.; Tunali A. Successful pregnancy and delivery in a patient with chronic myelogenous leukemya and management oj \cml with leukapheresis during pregnancy: a case report.JPN j. CLIN. Oncol.; 34(4):215-217, 2004 apr

  • 22. Peccatori F.A.; Azim H.A.; Orecchia R.; Hoekstra H.J.; Pavlidis N.; Kesic V.; Pentheroudakis G. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatmentand follow-up. Annal of Oncology; 24(6):vi160-vi170, 2013 jun.

  • 23. Chelysheva E.; Turkina A.; Shmakov R.; Zeifman A.; Aleshin S.; Shokhin I.; Guranda D.; Oksenjuk O.; mordanov S.; Kazakbaeva K.; chilov G. Placental transfer ofb tyrosine kinase innibitors used for chronic myeloid leucemia treatment. LEUK. Lymphoma. 1-6, 2017 jul.

  • 24.Jovelet C.; Seck A.; Mir O.; Simasotchi C.; Broutin S.; Goffinet F.; Bidart J.M.; Paci A.; Gil S. Variation in transplacental transfer of tyrosine kinase innibitors in the human perfused cotyledon model. Ann. Oncol..; 1500-1504, 2015 jul.

  • 25.Ault P.; Kantarjian H.; O`Brien S.; Faderl S.; Beran M.; Rios M.B.; Koller C.; Giles F.; Keating M.; Talpaz M.; Cortes J. Pregnancy among patients with chronic myeloid leucemia treated with imatinib. J. Clin. Oncol.; 24(7):1204-1208, 2006 mar

  • 26 Burwick R.M..; Kuo K.; Brewer D.; Druker B.J. Maternal, fetal and neonatal imatinib levels with treatment of chronic myeloid leucemia in pregnancy. Obstet. Gynecol.; 129(5):831-834, 2017 may

  • 27. Zanetti D.R.; Wight E. Chemotherapy of gynecological malignancies: contraindication during pregnancy? Ther Umsch. 62(1):53-60, 2005 jan

  • 28. Bitencourt C.R. Manual de direito penal. 2ª. Edição, Saraiva, 2005

  • 29. Toledo F.A. Principios básicos de direito penal. Ed. Saraiva, 1994.

  • 30. Wang D.P.; Liang M.Y.; Zhang X.H.; Wang S.M. clinical analisis about the management and the perinatal outcomes of pregnancy with chronic myeloid leucemia. Zonghua Fu Chan Ke Za Zhi. 45(10):735-739, 2010 oct

  • 31. Yin H.; Kristensen S.G.;Jiang H.; Rasmussen A.; Andersen C.Y. Srvival and growth of isolated pre-antral folicles from human ovarian medula tissue during long-term 3D cuture. Hum. Reprod.;31(7):1531-9, 2016 jul

  • 32. Salama M.; Isachenko V.; Isachenko E.; Rahimi G.; Mallman P. Updates in preserving reproductive potential of prepuberal girls with câncer. Systematic rewiew. Crit. Ver. Onco Hematol.;103:10-21, 2016 jul

  • 33. Salama M.; Woodruff T.K. New advances in ovarian autotransplantation to restore fertility in câncer patients. Cancer Metastasis Ver. 34(4):807-822, 2015 dec

  • 34. Behringer K.; Thielen I.; Mueller H.; Goergen H.; Eibl A.D.; Rosembrock J.; Halbsguth T.; Eichenauer D.A.; Fuchs M.; Reiners K.S.; Renno J.H.; van der vem K.; Kuehr M.; von Wolff m.; Diehl V.; Engert A.; Borchmann P. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma within the GermN Study Group HD 14 trial. Ann. Oncol.; 23(7):1818-1825, 2012 jul

  • 35. Oktay K. Spontaneous conceptions and live birth after heteretopic ovarian transplantation: is there a germline stem cell connection? Hum Reprod.; 21(6):1345-8, 2006 jun

  • 36. Driul L.; Londero A.P.; Papadakis C.; Candoni A.; Bertozzi S.; Fanin R.; Marchesoni D. Clin. Exp. Obstet. Gynecol.;39(4): 504-8, 2012

  • 37. Meirow D.; Raanani H.; Shapira M.; Brenghausen M.; Chaim S.D.; Aviel-Ronen S.; Amariglio N.; Sciff E.; Orvieto R.; Dor J. Fertlity Steril.;106:(467-74), 2016 aug

  • 38. Dolmans M.M.; Jadoul P.; Gilliaux S.; Amorim C.A.; Luyckx V.; Squifflet J. J.  A rewiew of 15 years of ovarian tissue bank activities. Assist. Reprod. Enet.; 30:305-314, 2013

  • 39. Fabbri R.; Macciocca M.; Vicenti R.; Pasquinelli G.; Caprara G.; valente S.; Seracchioli R.; Paradisi R. Long-term storage does not impact the quality of cryopreserved human ovarian tissue. J. Ovarian Res.; 9(1), 2016 aug

  • 40.Donnez J.; Dolmans M.M. Ovarian córtex transplantation: 60n reported live births brings the success and worldwide expansion of the technique towards clinical practice. J. Assist. Repord. Genet.; 32:1167-1170, 2015

  • 41.Zhang L.; Yan L.Y.; Zhi X.; Yan J.; Qiao J. Female fertility: is it safe to freeze. Chin. Med, J.; 128:390-397, 2015

  • 42.Lee S.J.; Schover L.R.; Partridge A.H. Americam Society of Clinical Oncology recommendations on fertility preservation in câncer patients. J. Clin. Oncol.; 24(18):2917-2931, 2006

  • 43.Dolmans M.M.; Marinescu C.; Saussoy P.; Van Langendonckt A.; Amorim C.; Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute limphoblastic leucemia is potentially unsafe. Blood; 116:2908-14, 2010

  • 44. Suhag V.; Sunita B.S.; Sarin A.; Singh A.K.; Dashottar S. Fertility preservation in yung with câncer; 4930; 134-139, 2015 jul-sep

  • 45. Zhang Y.; Xiao Z.; Wang Y.; Luo S.; Li X.; Li S. Gonadotropin-releasing hormone for preservation of ovarian function during chemotherapy in lymphoma patients of reproductive age: A summary based on 434 patients. Plos One; 8(11):e80444, 2013 oct

  • 46. Blumenfeld Z.; Zuckerman T. Repetead spontaneous pregnancies and successful deliveries after repested autologous stem cell transplantation and GnRH-Agonist treatment.  Oncologist; 15(1):59-60, 2010 jan

  • 47. Remerand G.; Merlin E.; Froissart R. Four successful pregnancies in patient with mucopolysaccharidosis type I terated by allogeneic boné marrow transplanatation. J. Inherit. Metab. Dis.; 2009 mar

  • 48.Gelbaya T.A.; Nardo L.G.; Hunter H.R.; Fitzgerald C.T.; Horne G.; Pease E.E. Cryopreserved –thawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study. Fertil. Steril.; 85(3):603-9, 2006

  • 49. Michelmann H.W.; Nayadu P. Cryopreservation of human embryos. Cell tissue bank.;7920;135-141, 2006

  • 50. Clough K.B.; Goffinet F.; Labib A.; Renoleau C.; Campana F.; de La Rochefordiere A. Laparoscopic unilateral ovarian transposition prior to irradiation: prospective study of 20 cases. Cancer; 77(12):2638-2645, 1996

O que você vai aprender

    Bem-vindo ao Curso
  • Primeiros Passos
  • Aulas e atividades complementares
  • Aula 1: Ciclo ovariano e reserva folicular
  • Aula 2: Preservação da fertilidade
  • Aula 3: Tratamentos e prognóstico da fertilidade
  • O que achou do curso?
  • Aula 4: Fertilidade Feminina e câncer na gravidez
    • Aula 4: Fertilidade Feminina e câncer na gravidez - Parte 1

      Vídeo
    • Aula 4: Fertilidade Feminina e câncer na gravidez - Parte 2

      Vídeo
    • Aula 4: Questionário

      Questionário
  • Revisão do Curso
    • Revisão dos Conteúdos do Curso

      Vídeo
  • Tutorial de como adquirir o certificado
  • Materiais de Apoio
  • Material de Apoio - Parte 1
    • Leitura: American Society of Clinical Oncology recommendations on fertility preservation in câncer patients

      Documento
    • Leitura: Cryopreservation of human embryos

      Documento
    • Leitura: Cryopreserved - thawed embryo transfer in natural or down-regulated hormonally controlled cycles - a retrospective study

      Documento
    • Leitura: Gonadal function and parenthood 20 years after treatment for chilhood lymphoma a cross- sectional study

      Documento
    • Leitura: Gonadotropin-releasing hormone for preservation of ovarian function during chemotherapy in lymphoma patients of reproductive age - A summary based on 434 patients

      Documento
    • Leitura: Laparoscopic unilateral ovarian transposition prior to irradiation prospective study of 20 cases

      Documento
    • Leitura: Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue endocrine studies, in vitro fertilization cycles, and live birth

      Documento
  • Material de Apoio - Parte 2
    • Leitura: Ovarian function follwing pelvic irradiation in prepubertal and pubertal girls and youn g adult women

      Documento
    • Leitura: Pregnancy among patients with chronic myeloid leucemia treated with imatinib

      Documento
    • Leitura: Reimplantation of cryopreserved ovarian tissue from patients with acute limphoblastic leucemia is potentially unsafe

      Documento
    • Leitura: Repetead spontaneous pregnancies and successful deliveries after repested autologous stem cell transplantation and GnRH-Agonist treatment

      Documento
    • Leitura: Treatment of hairy cell leucemia during pregnancy are purine analogues and rituximab viable therapeutics options

      Documento
    • Leitura: Updates in preserving reproductive potential of prepuberal girls with câncer

      Documento
    • Leituras recomendas

      Texto
    • Referências Bibliográficas

      Texto
Professores


Prof. Wilson Carrara

Formado em Medicina pela Universidade de São Paulo (USP). Doutor pela Faculdade de Medicina da USP e professor. Médico e sócio-diretor da Clínica Olimpíadas em São Paulo. Membro da Sociedade Brasileira de Reprodução Humana.  

Comece agora